GETI-B Getinge AB (publ)

27.56USD280.00 SEK · STO+0.72%Mkt Cap: 7.51B USDP/E: 26.95

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, a…

Institutional holders11 on file

Key Statistics

Company
Market Cap7.51B USD
Enterprise Value8.31B USD
Revenue (TTM)3.39B USD
Gross Profit1.64B USD
Net Income (TTM)222.25M USD
Revenue/Share12.45 USD
Last Price27.56 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees11.8K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0000202624
Valuation
P/E (Trailing)26.95
P/E (Forward)25.59
PEG1.50
EV/EBITDA13.95
EV/Revenue2.45
P/S2.21
P/B2.34
EPS (TTM)1.02 USD
EPS (Forward)1.08 USD
52W Range
17.3196% of range27.93
52W High27.93 USD
52W Low17.31 USD
Profitability
Gross Margin47.63%
Oper. Margin14.29%
EBITDA Margin17.56%
Profit Margin6.46%
ROE7.67%
ROA4.00%
ROIC8.74%
ROCE10.27%
Growth
Revenue Growth2.70%
Earnings Growth27.00%
Cash Flow & Leverage
Operating CF388.70M USD
CapEx (TTM)129.34M USD
FCF Margin9.88%
FCF Yield4.46%
Net Debt794.82M USD
Net Debt/EBITDA1.33
Net Debt/FCF2.37
Balance Sheet
Debt/Equity0.37
Current Ratio1.25
Quick Ratio0.72
Book Value/Sh11.80 USD
Cash/Share1.14 USD
Dividends
Fwd Div Rate0.47 USD
Trail. Div Rate0.47 USD
Div. Yield1.71%
5Y Avg Yield1.80%
Payout Ratio45.72%
Ex-Div DateApr 22, 2026
Pay Date—
Splits
Last Split4:1
Split DateNov 27, 2003
Analyst Consensus
Rating—
Target (Mean)26.86 USD
Upside (mean)-2.5%
Target Range19.00 USD – 31.50 USD
19.00-2.5% to mean31.50
# Analysts11
Ownership
Shares Out.254.15M
Float178.53M
Insiders15.20%
Institutions62.44%
Technical
SMA 5025.49 (+8.1%)
SMA 20021.59 (+27.7%)
Beta0.80
S&P 52W Chg12.00%
Avg Vol (30d)480.93K
Avg Vol (10d)429.40K
Technical Indicators
RSI (14)62.6
MACD5.7953
MACD Signal6.5969
MACD Hist.-0.8016
BB Upper28.06 USD
BB Middle27.15 USD
BB Lower26.24 USD
BB Width6.74%
ATR (14)0.4522 USD
Vol Ratio (20d)0.78x

About Getinge (STO: GETI-B)

›

Getinge (STO: GETI-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 11,847 employees.

The shares were at 280.00 SEK on 19 November 2026, up 38.3% over 52 weeks. Its 52-week range is 175.90 SEK to 283.80 SEK: the price is 1.3% below the high and 59.2% above the low.

At a market capitalisation of 76.26B SEK, it trades at 26.9 times trailing earnings and 25.6 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, so GETI-B is valued in line with them. It pays a dividend yielding 1.71% (it pays out 46% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

Getinge reports return on equity of 7.7%, an operating margin of 14.3% and revenue up 2.7% year over year.

Its debt exceeds its cash by 8.08B SEK, a debt-to-equity ratio of 0.37. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 11 analysts cover the stock; their mean price target of 272.91 SEK is 2.5% below the current price. The next earnings report is expected on 26 January 2027.